These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9509271)

  • 41. Identification of insulin-dependent diabetes mellitus before the onset of clinical symptoms.
    Riley WJ; Winter WE; Maclaren NK
    J Pediatr; 1988 Feb; 112(2):314-6. PubMed ID: 3276866
    [No Abstract]   [Full Text] [Related]  

  • 42. Soluble adhesion molecules in Finnish schoolchildren with signs of preclinical type 1 diabetes.
    Toivonen A; Kulmala P; Rahko J; Ilonen J; Knip M
    Diabetes Metab Res Rev; 2004; 20(1):48-54. PubMed ID: 14737745
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Immune markers in preclinical phases of diabetes type 1. Role of cytokines, adhesion molecules and peripheral blood lymphocyte subpopulations in the pathogenesis and prediction of insulin-dependent diabetes].
    Kretowski A; Kinalska I
    Przegl Lek; 2000; 57(12):736-42. PubMed ID: 11398599
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prediction of type 1 diabetes mellitus--a report on three cases.
    Bruining GJ; Molenaar JL; de Jongh BM; Aarsen RS; Visser HK
    Eur J Pediatr; 1985 Jan; 143(3):175-8. PubMed ID: 3987708
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of a new anti-glutamic acid decarboxylase (GAD) enzyme-linked immunosorbent assay (ELISA) with radioimmunoassay methods: a multicenter study.
    Wild T; Scherbaum WA; Gleichmann H; Landt M; Santiago J; Endl J; Landgraf R; Cavallo MG; Ganz M; Pozzilli P
    Horm Metab Res; 1997 Aug; 29(8):403-6. PubMed ID: 9288579
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prediction and diagnosis of type 1 diabetes using beta-cell autoantibodies.
    Batstra MR; Aanstoot HJ; Herbrink P
    Clin Lab; 2001; 47(9-10):497-507. PubMed ID: 11596913
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacological approaches to the prevention of autoimmune diabetes.
    Winter WE; House DV; Schatz D
    Drugs; 1997 Jun; 53(6):943-56. PubMed ID: 9179526
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identifying the pre-diabetic state in type I diabetics: condition for early intervention.
    Becker F; Buschler H; Scherer S; Petzoldt H; Sauer H; Bretzel RG; Federlin K
    J Autoimmun; 1990 Oct; 3(5):639-42. PubMed ID: 2252532
    [No Abstract]   [Full Text] [Related]  

  • 49. [Presence of markers predictive of type I pre-diabetes mellitus status in relatives of patients with type I diabetes mellitus].
    Rodríguez-Villar C; Conget I; Esmatjes E; Levy I; Calvet J; Figuerola D; Bergua M; Gutiérrez A; Miralles J; Millán M; Peig M; Gomis R
    Med Clin (Barc); 1996 Sep; 107(10):371-4. PubMed ID: 9036240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictive medicine: from molecular genetics to prevention. Application to insulin-dependent diabetes mellitus.
    Bach JF
    Isr J Med Sci; 1992 Feb; 28(2):111-2. PubMed ID: 1559793
    [No Abstract]   [Full Text] [Related]  

  • 51. Natural history and prediction of type 1 diabetes.
    Di Mario U; Dotta F
    Ann Ig; 1992; 4(3):153-7. PubMed ID: 1284514
    [No Abstract]   [Full Text] [Related]  

  • 52. Immunointervention in type 1 (insulin-dependent) diabetes mellitus.
    Keymeulen B; Somers G
    Acta Clin Belg; 1993; 48(2):86-95. PubMed ID: 8392249
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intervention therapies for insulin-dependent diabetes.
    Muir A; Schatz DA; Pozzilli P; MacLaren NK
    Autoimmunity; 1993; 16(4):301-10. PubMed ID: 8025209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune Interventions for Type 1 Diabetes Mellitus.
    Nambam B; Bratina N; Schatz D
    Diabetes Technol Ther; 2017 Feb; 19(S1):S74-S81. PubMed ID: 28192018
    [No Abstract]   [Full Text] [Related]  

  • 55. The Early Diabetes Intervention Program--is early actually late?
    Bergman M
    Diabetes Metab Res Rev; 2014 Nov; 30(8):654-8. PubMed ID: 25400067
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prediabetes in children: natural history, diagnosis, and preventive strategies.
    Kulmala P
    Paediatr Drugs; 2003; 5(4):211-21. PubMed ID: 12662117
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Latent autoimmune diabetes mellitus in adults].
    Luo M
    Zhonghua Nei Ke Za Zhi; 1997 Mar; 36(3):151-2. PubMed ID: 10374306
    [No Abstract]   [Full Text] [Related]  

  • 58. [Detection of subjects at risk of type 1 diabetes. GOFEDI. Groupe Ouest-France pour l'Etude du Diabète Insulino-dépendant].
    Maugendre D; Bardet S; Rohmer V; Stetieh H; Marre M; Limal JM; Charbonnel B; Saï P; Allannic H
    Rev Med Interne; 1993 Jan; 14(1):25-31. PubMed ID: 8362105
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Family awareness. Monitoring diabetes risk.
    Hieronymus L; Geil P
    Diabetes Self Manag; 2014; 31(4):22-4, 26. PubMed ID: 25137832
    [No Abstract]   [Full Text] [Related]  

  • 60. Predictors of progression to Type 1 diabetes: preparing for immune interventions in the preclinical disease phase.
    Gorus FK; Keymeulen B; Veld PA; Pipeleers DG
    Expert Rev Clin Immunol; 2013 Dec; 9(12):1173-83. PubMed ID: 24215407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.